This article is part of the supplement: 24th Congress of the International Association for Breast Cancer Research. Advances in human breast cancer research: preclinical models
Transgenic models are predictive: the herceptin and flavopiridol experience
Breast Cancer Res 2003, 5(Suppl 1):28 doi:10.1186/bcr687
No comments have yet been made on this article.